Close Menu

Patent Concerns

Direct-to-consumer genetic testing company 23andMe announced earlier this week that it has received its first patent. As our sister publication BioArray News reports, the patent, US Patent No. 8,187,811, covers a method for determining an individual's susceptibility to Parkinson's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.